This is a public record generated listing.
Assets of Connecticut Pharmaceutical Company
Listing Information
Attachments
Assets of Connecticut Pharmaceutical Company
Price: $10,000,000.00
Other Item Info
Item #: nysbke_296030
Created: 09/15/2020
Category: Business Property > All Assets or Going Concerns > Pharmaceuticals & Biotechnology
Sale Location: White Plains, New York
Sale Date: Wed. Sep 30, 2020
Created: 09/15/2020
Category: Business Property > All Assets or Going Concerns > Pharmaceuticals & Biotechnology
Sale Location: White Plains, New York
Sale Date: Wed. Sep 30, 2020
Seller Info
Eli Vonnegut
Debtor's Attorney
450 Lexington Avenue
New York, NY 10017
212-450-4331
Debtor's Attorney
450 Lexington Avenue
New York, NY 10017
212-450-4331
Bankruptcy Info
Case #: 7:19-bk-23649
Case Title: Purdue Pharma L.P.
Court: New York Southern Bankruptcy Court
Chapter: 11
View Case Docket
Case Title: Purdue Pharma L.P.
Court: New York Southern Bankruptcy Court
Chapter: 11
View Case Docket
Description
Sale of assets of Purdue Pharma L.P. Which includes:
- the Real Property;
- inventory (other than inventory relating to Oxycodone);
- machinery and equipment at the Real Property;
- supplies at the Real Property;
- the Assigned Contracts and the rights thereunder;
- information technology assets used at the Real Property in the operation of the Business;
- Copyrights and Know-How (other than Oxycodone IP) for the manufacture of APIs at the Real Property;
- certain Patents;
- Copyrights and Know-How for the manufacture of certain APIs in development;
- certain Permits and pending applications therefor;
- all vehicles at the Real Property;
- all Books and Records (other than Retained Books and Records);
- all employment-related agreements with Transferred Employees;
- all causes of action related to the Business, the Purchased Assets or the Assumed Liabilities (other than certain retained causes of Action);
- all avoidance actions against trade creditors with whom the Purchaser continues to conduct business or Transferred Employees;
- the drug master files and batch records for the API and Purchased Products; and
- all goodwill associated with any of the foregoing.
Assets for sale is more described in attached PDF.
Financial Overview
Income and Expenses ($)
months
Revenue/Gross Income:
Total Expenses:
Cash Flow:
Asset and Liability Summary ($)
Receivables:
Inventory:
FF&E:
Real Estate:
Total Assets:
Liabilities to assume: